In Vitro Transcriptome Analysis of Cobalt Boride Nanoparticles on Human Pulmonary Alveolar Cells
Ontology highlight
ABSTRACT: In this study, we first characterized commercially available cobalt boride (Co2B) nanoparticles (NPs) using X-ray crystallography (XRD), transmission electron microscope (TEM), scanning electron microscope (SEM) and energy-dispersive X-ray spectroscopy (EDX) techniques. Next, we selected 3-(4,5-dimethyl-thiazol-2-yl) 2,5-diphenyltetrazolium bromide (MTT), neutral red (NR) and lactate dehydrogenase (LDH) release assays for cell viability against Co2B NPs exposure and found that cell viability tests unveiled LC20 value for Co2B NPs was 310.353 mg/L. Moreover, we performed cytotoxicity tests using human pulmonary alveolar epithelial cells (HPAEpiC) since the interaction with the nanoparticles generally starts with inhaling from the air. We performed whole-genome microarray analysis to reveal the global gene expressions differentiations of HPAEpiC cells after Co2B NPs application and found that our analysis displayed 719 genes expression differentiations (FC≥2) after 40.000 genes analysis. Visualization and integrated discovery (DAVID) analysis showed that there are interactions between various gene pathways and NPs administration. Based on gene ontology biological processes analysis, we found that P53 signaling pathway, cell cycle, cancer affecting genes and growth factors were mostly affected by the Co2B NPs. In conclusion, we observed that Co2B NPs would be a safe nano-molecule for industrial, environmental and medical applications.
ORGANISM(S): Homo sapiens
SUBMITTER: Mehmet Enes Arslan
PROVIDER: E-MTAB-9035 | biostudies-arrayexpress |
REPOSITORIES: biostudies-arrayexpress
ACCESS DATA